Dapagliflozin 5mg"'"'"'"

Dec 26, 2023

Dapagliflozin
GLIDAPAFLOZIN  is a medication used in the management of type 2 diabetes mellitus. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. GLIDAPAFLOZIN  works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and a reduction in blood glucose levels.
GLIDAPAFLOZIN  inhibits SGLT2, a protein responsible for reabsorbing glucose in the kidneys. By blocking this protein, dapagliflozin promotes the excretion of excess glucose in the urine, lowering blood glucose levels.
GLIDAPAFLOZIN  is indicated for the treatment of type 2 diabetes mellitus in adults.
It is often prescribed as part of a comprehensive treatment plan that includes diet, exercise, and other antidiabetic medications.
GLIDAPAFLOZIN  has been shown to have additional cardiovascular benefits. It may reduce the risk of cardiovascular events and hospitalization for heart failure in certain patient populations.
It can also lead to a mild diuretic effect, resulting in decreased blood pressure.
GLIDAPAFLOZIN  mechanism of action involves the kidneys, so its use may be associated with changes in kidney function. Regular monitoring of kidney function is typically recommended.
GLIDAPAFLOZIN  may lead to modest weight loss, which can be beneficial for individuals with type 2 diabetes who are overweight or obese.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/glidapaflozin-5-133428
 

SHARE WITH